You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

January 2003

Volume 55, Issue 1

Pages 1–113

  1. Viewpoint

    1. Top of page
    2. Viewpoint
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/Pharmacodynamics
    6. Pharmacogenetics
    7. Drug Disposition
    8. Drug Interactions
    9. Short Report
    10. Letter
    1. You have free access to this content
  2. Pharmacokinetics

    1. Top of page
    2. Viewpoint
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/Pharmacodynamics
    6. Pharmacogenetics
    7. Drug Disposition
    8. Drug Interactions
    9. Short Report
    10. Letter
    1. You have free access to this content
      Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria (pages 6–13)

      Bernd C. Schwahn, Dieter Hafner, Thomas Hohlfeld, Nina Balkenhol, Maurice D. Laryea and Udo Wendel

      Version of Record online: 14 JAN 2003 | DOI: 10.1046/j.1365-2125.2003.01717.x

    2. You have free access to this content
      Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability (pages 14–22)

      Eva Arlander, Jan Sjövall, Jörgen Sörstad, Carina Norsten-Höög and Lars L. Gustafsson

      Version of Record online: 14 JAN 2003 | DOI: 10.1046/j.1365-2125.2003.01732.x

    3. You have free access to this content
      Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation (pages 23–31)

      Hussain Mulla, Fazal Nabi, Sanjiv Nichani, Graham Lawson, R. K. Firmin and David R. Upton

      Version of Record online: 14 JAN 2003 | DOI: 10.1046/j.1365-2125.2003.01735.x

    4. You have free access to this content
  3. Pharmacodynamics

    1. Top of page
    2. Viewpoint
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/Pharmacodynamics
    6. Pharmacogenetics
    7. Drug Disposition
    8. Drug Interactions
    9. Short Report
    10. Letter
    1. You have free access to this content
      Biomarkers for the effects of benzodiazepines in healthy volunteers (pages 39–50)

      S. J. De Visser, J. P. Van Der Post, P. P. De Waal, F. Cornet, A. F. Cohen and J. M. A. Van Gerven

      Version of Record online: 11 NOV 2002 | DOI: 10.1046/j.1365-2125.2002.t01-10-01714.x

  4. Pharmacokinetics/Pharmacodynamics

    1. Top of page
    2. Viewpoint
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/Pharmacodynamics
    6. Pharmacogenetics
    7. Drug Disposition
    8. Drug Interactions
    9. Short Report
    10. Letter
    1. You have free access to this content
      Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans (pages 51–61)

      Julia Kirchheiner, Ingolf Meineke, Nadine Steinbach, Christian Meisel, Ivar Roots and Jürgen Brockmöller

      Version of Record online: 14 JAN 2003 | DOI: 10.1046/j.1365-2125.2003.01712.x

  5. Pharmacogenetics

    1. Top of page
    2. Viewpoint
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/Pharmacodynamics
    6. Pharmacogenetics
    7. Drug Disposition
    8. Drug Interactions
    9. Short Report
    10. Letter
    1. You have free access to this content
    2. You have free access to this content
      Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism (pages 68–76)

      Christoph Sachse, Upinder Bhambra, Gillian Smith, Tracy J. Lightfoot, Jennifer H. Barrett, Jenna Scollay, R. Colin Garner, Alan R. Boobis, C. Roland Wolf, Nigel J. Gooderham and The Colorectal Cancer Study Group

      Version of Record online: 14 JAN 2003 | DOI: 10.1046/j.1365-2125.2003.01733.x

  6. Drug Disposition

    1. Top of page
    2. Viewpoint
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/Pharmacodynamics
    6. Pharmacogenetics
    7. Drug Disposition
    8. Drug Interactions
    9. Short Report
    10. Letter
    1. You have free access to this content
      Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans (pages 77–85)

      Zaiqi Wang, Stephen D. Hall, Juan F. Maya, Lang Li, Ali Asghar and J. C. Gorski

      Version of Record online: 14 JAN 2003 | DOI: 10.1046/j.1365-2125.2003.01731.x

  7. Drug Interactions

    1. Top of page
    2. Viewpoint
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/Pharmacodynamics
    6. Pharmacogenetics
    7. Drug Disposition
    8. Drug Interactions
    9. Short Report
    10. Letter
    1. You have free access to this content
    2. You have free access to this content
      Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects (pages 94–99)

      Kelvin J. Cooper, Paul D. Martin, Aaron L. Dane, Mike J. Warwick, Ali Raza and 1 Dennis W. Schneck 2

      Version of Record online: 14 JAN 2003 | DOI: 10.1046/j.1365-2125.2003.01720.x

    3. You have free access to this content
  8. Short Report

    1. Top of page
    2. Viewpoint
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/Pharmacodynamics
    6. Pharmacogenetics
    7. Drug Disposition
    8. Drug Interactions
    9. Short Report
    10. Letter
    1. You have free access to this content
      MMR vaccine and idiopathic thrombocytopaenic purpura (pages 107–111)

      Corri Black, James A. Kaye and Hershel Jick

      Version of Record online: 14 JAN 2003 | DOI: 10.1046/j.1365-2125.2003.01790.x

  9. Letter

    1. Top of page
    2. Viewpoint
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/Pharmacodynamics
    6. Pharmacogenetics
    7. Drug Disposition
    8. Drug Interactions
    9. Short Report
    10. Letter
    1. You have free access to this content

SEARCH

SEARCH BY CITATION